Help
explore insurance coverage, including understanding anticipated out-of-pocket costs
The SPEVIGO Patient Support Program is a complimentary support program here to help you on your journey. Get connected to a dedicated team member who can answer your questions, explore financial support, and help you prepare for treatment.
explore insurance coverage, including understanding anticipated out-of-pocket costs
potential financial assistance options, including the SPEVIGO Copay Program*
you to resources about GPP, including how it may affect your body, how SPEVIGO works, what to expect on treatment, how SPEVIGO is administered, and how to inject it
Through the SPEVIGO Copay Program, you may be able to pay as little as $0 per treatment if you have commercial insurance. Sign up through the SPEVIGO Patient Support Program to get started. Eligible patients will receive their SPEVIGO Copay Program card by email.
For questions about the SPEVIGO Copay Program or to learn more about
other potential ways to save, contact the SPEVIGO Patient Support Program
at 1-833-SPEVIGO (1-833-773-8446), Monday-Friday, 8AM-8PM ET.
Once your doctor prescribes SPEVIGO, their office can enroll you in the SPEVIGO Patient Support Program, or you can enroll online here
Within 24 hours you’ll receive a phone call welcoming you to the program and offering support
You will then be provided with customized resources and, if needed, connected to other team members who can help
The SPEVIGO Patient Support Program team does not provide medical advice and is not a substitute for your medical team. Your doctor should always be your main resource for any questions about your health and medical care.
*Eligibility and enrollment required. For use only with commercial prescription insurance. Valid for US patients, aged 12 years and older. Must be used for an FDA-approved indication. Additional terms and conditions apply.
GPP=generalized pustular psoriasis.
SPEVIGO is a prescription medicine used to treat generalized pustular psoriasis (GPP) in adults and children 12 years of age and older who weigh at least 88 pounds (40 kg). It is not known if SPEVIGO is safe and effective in children under 12 years of age or who weigh less than 88 pounds (40 kg).
Do not receive SPEVIGO if you or your child have had a severe or life-threatening allergic reaction to spesolimab-sbzo or any of the ingredients in SPEVIGO.
SPEVIGO may cause serious side effects, including:
Tell your healthcare provider about all the medicines you or your child take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
The most common side effects of SPEVIGO given in a vein (intravenously) for GPP flare treatment include:
The most common side effects of SPEVIGO when given under the skin (subcutaneously) for treatment of GPP when not experiencing a flare include:
These are not all of the possible side effects of SPEVIGO. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.